Incyte Corporation
Clinical trials sponsored by Incyte Corporation, explained in plain language.
-
Experimental cancer drug tested in advanced tumors – study halted early
Disease control TerminatedThis early-stage study tested an experimental drug called INCB062079 in 25 people with advanced liver cancer (hepatocellular carcinoma) and several other solid tumors. The main goal was to check the drug's safety and find the highest dose people could tolerate. The study was term…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Blood cancer anemia drug trial halted early
Disease control TerminatedThis study tested an experimental drug called INCB000928 in 22 people with anemia caused by myelodysplastic syndromes (MDS) or multiple myeloma. The goal was to find a safe dose and see if it could improve red blood cell counts. The trial was stopped early, so results are limited…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage trial tested an experimental drug called INCB059872 in 116 people with advanced solid tumors or blood cancers that had stopped responding to standard treatments. The study aimed to find a safe dose and check for side effects, both when the drug was given alone an…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 04, 2026 16:31 UTC